The Bispecific PSMAxCD3 Antibody CC-1 in Patients with Castration Resistant Prostate Carcinoma

Clinical trial NCT04104607 · RECRUITING

Trial details

NCT number: NCT04104607
Sponsor: University Hospital Tuebingen
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Castration-Resistant Prostatic Cancer

Start date: 2019-11-15
Primary completion: 2025-12-31
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.